Document is current
Any future updates will be listed below
-
Authors
,
Bussu, Giorgia https://orcid.org/0000-0002-6071-3964
Jones, Emily J. H.
Charman, Tony
Johnson, Mark H.
Buitelaar, Jan K.
-
Funding
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (642996)
Innovative Medicines Initiative (115300)
UK Medical Research Council (G0701484, MR/K021389/1)
Seventh Framework Programme (FP7/2007-2013)
- License Information
-
More Information
Article History
Received: 5 November 2018
Accepted: 27 February 2019
First Online: 15 March 2019
Ethics approval and consent to participate
: All procedures were in agreement with ethical approval granted by the London Central NREC (approval codes 06/MRE02/73, 08/H0718/76), and one or both parents gave informed consent to participate in the study.
: Not applicable.
: JKB has been a consultant to/member of, an advisory board of, and/or a speaker for Janssen Cilag BV, Eli Lilly, Lundbeck, Shire, Roche, Novartis, Medice, and Servier. He is neither an employee nor a stock shareholder of any of these companies. TC has received research grant support from the Medical Research Council (UK), the National Institute of Health Research, Horizon 2020 and the Innovative Medicines Initiative (both European Commission), MQ, Autistica, FP7 (European Commission), the Charles Hawkins Fund, and the Waterloo Foundation. He has served as a consultant to F. Hoffmann-La Roche, Ltd. He has received royalties from Sage Publications and Guilford Publications. The present work is unrelated to these relationships. The other authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
